Semnur Pharmaceuticals

Semnur Pharmaceuticals is a specialty pharmaceutical company in the late clinical stage, dedicated to the development and commercialization of novel non-opioid pain therapies. Semnur's lead program, SP-102, is the first non-opioid novel gel formulation in development for the treatment of moderate to severe chronic radicular pain/sciatica through epidural administration.